Oct 17, 2022

Cancer vaccine could be ready for use by 2030, say BioNTech founders

Posted by in category: biotech/medical

Lessons from COVID vaccine development and approval can aid the process.

According to Uğur Şahin and Özlem Türeci, the founders of the German company BioNTech, mRNA vaccines that can help target cancer could be ready for use before the end of this decade, The Guardian.


BioNTech’s big pivot.

Leave a reply